SWK Holdings Corp is a company that operates in the finance sector. Its business model revolves around investments in various sectors, including life sciences, medical devices, and healthcare services. As an asset manager, SWK Holdings Corp provides capital solutions to companies in these sectors through funding their growth initiatives. By offering customized financing solutions, SWK Holdings Corp facilitates the progress and success of its investment partners. The company focuses on providing financial support to established and emerging healthcare companies, contributing to advancements and innovations in the healthcare industry. Through its strategic investments, SWK Holdings Corp seeks to generate attractive risk-adjusted returns for its shareholders.

SWK Holdings Corp is primarily active in the pharmaceutical and healthcare industries.

The main competitors of SWK Holdings Corp in the market are Acamar Partners Acquisition Corp, Ally Financial Inc, Apollo Investment Corp, and BlackRock Capital Investment Corp, among others.

SWK Holdings Corp, founded in 1996, is a specialized finance company focusing on the acquisition and management of cash flows and investments. With a diverse portfolio, SWK Holdings provides customized financing solutions to small and medium-sized companies in the life sciences sector. The company has a strong history of strategic partnerships and investments, enabling it to support the growth and development of innovative healthcare companies. SWK Holdings Corp's expertise and experience have made it a trusted partner within the industry, consistently delivering value and driving long-term success for its investments.

SWK Holdings Corp has achieved several significant milestones since its inception. Over the years, the company has successfully built a diverse portfolio of investments in the healthcare sector. SWK Holdings Corp has demonstrated a strong track record of executing strategic investments, enhancing shareholder value, and delivering attractive returns. The company's commitment to fostering long-term partnerships and its expertise in navigating the evolving healthcare industry have contributed to its success. Additionally, SWK Holdings Corp has consistently demonstrated solid financial performance and an ability to adapt to changing market conditions. These accomplishments have solidified the company's position as a leading player in the healthcare investment space.

SWK Holdings Corp is primarily present in the United States.

SWK Holdings Corp represents values of integrity, trust, and transparency. The company follows a corporate philosophy that focuses on long-term sustainability and delivering value to its shareholders. SWK Holdings Corp takes a client-centered approach, striving to provide innovative solutions and customized financing that meet the specific needs of its partners. With a commitment to fostering strong relationships and delivering excellent customer service, SWK Holdings Corp aims to be a trusted partner in the healthcare sector. Through its expertise and dedication, the company strives to create mutually beneficial opportunities that drive growth and success for both SWK and its partners.

Analysts currently set an average price target of 18.87 USD for the SWK Holdings stock (median: 18.87 USD), implying +18.7 % versus the latest price. The consensus is based on 7 analyst ratings.

SWK Holdings Analyst Price Targets 2026

6 analysts currently rate the SWK Holdings stock: 0 recommend buying, 3 holding and 3 selling.

SWK Holdings Analyst Price Targets 2026

Converted at the current exchange rate, the SWK Holdings share trades at 13.81 EUR (15.90 USD).

The SWK Holdings share (SWKH) is listed on 1 stock exchanges, including: NASDAQ (SWKH).

The SWK Holdings Corp is a company that specializes in acquiring and managing interests in companies in the pharmaceutical industry. The company's business model is based on investing in companies that develop innovative treatment methods or novel technologies in the healthcare industry. The main goal of SWK Holdings Corp is to invest money to operate or finance a wide range of companies in the healthcare industry. They invest in companies that have not yet brought their products to market, but have developed a promising technology or treatment method that is currently in development or testing. The company has several divisions in which it operates. One of these divisions is the medical devices and equipment sector. The company invests in innovative instruments that can improve clinical outcomes and optimize patient care. These devices have the potential to change the way healthcare is provided and help users develop new treatment options. Another area in which SWK Holdings Corp is active is the pharmaceutical industry. The company invests in pharmaceutical companies that develop new treatments that can improve healthcare and offer patients more options. These investments enable companies to continue their research and development and establish their products in the market. In addition to the above-mentioned divisions, SWK Holdings Corp also invests in companies involved in biomedical research. These companies are working on the development of new drugs and therapies that can improve healthcare and revolutionize patient care approaches. The products made by the companies in which SWK Holdings Corp is involved are extremely diverse. Some of the products include novel devices that can be used in surgery to increase accuracy and efficiency. Other products can help patients manage chronic pain or illnesses by offering an improved treatment option. As part of their business model, SWK Holdings Corp aims to advance innovation assessment and optimize hospital processes. They focus on developing products that can improve healthcare and increase the efficiency of hospital operations. This leads to better patient care and improved outcomes. Overall, the business model of SWK Holdings Corp is focused on investing in promising companies in the healthcare industry. Through their investments in innovative technologies and treatment methods, they support the development of products that improve healthcare, optimize processes, and benefit patients.

The revenue cannot currently be calculated for SWK Holdings.

The expected profit of SWK Holdings is 26.15 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of SWK Holdings is currently 7.40. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the SWK Holdings stock.

The P/S cannot be calculated for SWK Holdings currently.

The Eulerpool Quality Score for SWK Holdings is 4/10.

The ISIN of SWK Holdings is US78501P2039. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of SWK Holdings is A140F1. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of SWK Holdings is SWKH. The ticker symbol is used to trade SWK Holdings shares on the stock exchange.

Over the past 12 months, SWK Holdings paid a dividend of 4.00 USD . This corresponds to a dividend yield of about 25.16 %. For the coming 12 months, SWK Holdings is expected to pay a dividend of 4.00 USD.

The current dividend yield of SWK Holdings is 25.16 %.

SWK Holdings paid dividends every year for the past 1 years.

For the upcoming 12 months, dividends amounting to 4.00 USD are expected. This corresponds to a dividend yield of 25.16 %.

SWK Holdings is assigned to the 'Finance' sector.

To receive the latest dividend of SWK Holdings from amounting to 4 USD, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

The dividends of SWK Holdings are distributed in USD.